These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26084349)

  • 41. Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes.
    Alexander JS; Chervenak R; Weinstock-Guttman B; Tsunoda I; Ramanathan M; Martinez N; Omura S; Sato F; Chaitanya GV; Minagar A; McGee J; Jennings MH; Monceaux C; Becker F; Cvek U; Trutschl M; Zivadinov R
    J Neurol Sci; 2015 Aug; 355(1-2):84-9. PubMed ID: 26073484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
    Augutis K; Axelsson M; Portelius E; Brinkmalm G; Andreasson U; Gustavsson MK; Malmeström C; Lycke J; Blennow K; Zetterberg H; Mattsson N
    Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.
    Kuchling J; Ramien C; Bozin I; Dörr J; Harms L; Rosche B; Niendorf T; Paul F; Sinnecker T; Wuerfel J
    Mult Scler; 2014 Dec; 20(14):1866-71. PubMed ID: 24781284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CSF dynamics and brain volume in multiple sclerosis are associated with extracranial venous flow anomalies: a pilot study.
    Zamboni P; Menegatti E; Weinstock-Guttman B; Schirda C; Cox JL; Malagoni AM; Hojnacki D; Kennedy C; Carl E; Dwyer MG; Bergsland N; Galeotti R; Hussein S; Bartolomei I; Salvi F; Ramanathan M; Zivadinov R
    Int Angiol; 2010 Apr; 29(2):140-8. PubMed ID: 20351670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of leukemia inhibitory factor in the cerebrospinal fluid of patients with multiple sclerosis.
    Mashayekhi F; Salehi Z
    J Clin Neurosci; 2011 Jul; 18(7):951-4. PubMed ID: 21570299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
    Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.
    Simone IL; Federico F; Trojano M; Tortorella C; Liguori M; Giannini P; Picciola E; Natile G; Livrea P
    J Neurol Sci; 1996 Dec; 144(1-2):182-90. PubMed ID: 8994122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of cerebellar abnormalities in neuromyelitis optica--a comparison with multiple sclerosis and healthy controls.
    Weier K; Eshaghi A; Magon S; Andelova M; Radue EW; Kappos L; Azimi AR; Sahraian MA; Sprenger T
    Mult Scler; 2015 May; 21(6):757-66. PubMed ID: 25480863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, MRI, CSF and electrophysiological findings in different stages of multiple sclerosis.
    Rot U; Mesec A
    Clin Neurol Neurosurg; 2006 Mar; 108(3):271-4. PubMed ID: 16378679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis.
    Greco A; Minghetti L; Puopolo M; Cannoni S; Romano S; Pozzilli C; Levi G
    J Neurol Sci; 2004 Sep; 224(1-2):23-7. PubMed ID: 15450767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative MRI and cerebrospinal fluid inflammatory mediators in Brazilian patients with relapsing-remitting multiple sclerosis before and after treatment with immunomodulators: a longitudinal study.
    Ruocco HH; Brandão CO; Farias AS; Oliveira C; Oliveira EC; Cendes F; Damasceno BP; Santos LM
    Neuroimmunomodulation; 2012; 19(5):277-82. PubMed ID: 22472803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential patterns of spinal cord and brain atrophy in NMO and MS.
    Liu Y; Wang J; Daams M; Weiler F; Hahn HK; Duan Y; Huang J; Ren Z; Ye J; Dong H; Vrenken H; Wattjes MP; Shi FD; Li K; Barkhof F
    Neurology; 2015 Apr; 84(14):1465-72. PubMed ID: 25762714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.
    Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
    J Proteomics; 2010 Apr; 73(6):1117-32. PubMed ID: 20093204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upper cervical spinal cord cross-sectional area in relapsing remitting multiple sclerosis: application of a new technique for measuring cross-sectional area on magnetic resonance images.
    Mann RS; Constantinescu CS; Tench CR
    J Magn Reson Imaging; 2007 Jul; 26(1):61-5. PubMed ID: 17659556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
    Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
    Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemispheric asymmetry measured by texture analysis and diffusion tensor imaging in two multiple sclerosis subtypes.
    Savio S; Hakulinen U; Ryymin P; Hagman S; Dastidar P; Soimakallio S; Elovaara I; Eskola H
    Acta Radiol; 2015 Jul; 56(7):844-51. PubMed ID: 25024438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion.
    Eisele P; Szabo K; Griebe M; Wolf ME; Hennerici MG; Gass A
    Mult Scler; 2014 Sep; 20(10):1391-5. PubMed ID: 24323819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study.
    Zivadinov R; Schirda C; Dwyer MG; Haacke ME; Weinstock-Guttman B; Menegatti E; Heininen-Brown M; Magnano C; Malagoni AM; Wack DS; Hojnacki D; Kennedy C; Carl E; Bergsland N; Hussein S; Poloni G; Bartolomei I; Salvi F; Zamboni P
    Int Angiol; 2010 Apr; 29(2):158-75. PubMed ID: 20351672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.